Labcorp Holdings (LH) Capital Expenditures (2009 - 2026)

Labcorp Holdings has disclosed Capital Expenditures across 18 years of filings, most recently posting $121.0 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $121.0 million, down 3.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $429.5 million (down 10.91% YoY), and the FY2025 annual result was $434.5 million, down 11.31% from the prior year.
• Capital Expenditures came in at $121.0 million for Q1 2026 at Labcorp Holdings, down from $123.9 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $167.2 million in Q4 2023 to a low of $77.9 million in Q2 2025.
• The 5-year median for Capital Expenditures is $115.8 million (2024), against an average of $113.4 million.
• Across the five-year window, Capital Expenditures jumped 71.1% in 2024 and tumbled 39.24% in 2025, its largest moves.
• Labcorp Holdings' Capital Expenditures stood at $99.1 million in 2022, then soared by 68.72% to $167.2 million in 2023, then slumped by 32.95% to $112.1 million in 2024, then rose by 10.53% to $123.9 million in 2025, then slipped by 2.34% to $121.0 million in 2026.
• The last three Capital Expenditures figures came in at $121.0 million (Q1 2026), $123.9 million (Q4 2025), and $106.7 million (Q3 2025), per Business Quant data.